YGION Biomedical
Vienna
About YGION Biomedical
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $16.3M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: ygion.bio
- Phone: +43 (0)1 235 01 50
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ygion-biomedical-10525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.